Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3069891-91-1
2. Schembl31292236
3. Bdbm761035
4. Mrt-8102
5. Ex-a15659
6. Us20250243180, Compound 14
7. 2-pyrimidineacetamide, N-[[3,5-dichloro-4-(2,6-dioxo-3-piperidinyl)phenyl]methyl]-alpha,alpha,5-trimethyl-
8. N-[[3,5-dichloro-4-(2,6-dioxo-3-piperidinyl)phenyl]methyl]-alpha,alpha,5-trimethyl-2-pyrimidineacetamide
| Molecular Weight | 449.3 g/mol |
|---|---|
| Molecular Formula | C21H22Cl2N4O3 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 101 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 655 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
45
PharmaCompass offers a list of Ghv7HF46BG API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ghv7HF46BG manufacturer or Ghv7HF46BG supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ghv7HF46BG manufacturer or Ghv7HF46BG supplier.
A Ghv7HF46BG manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ghv7HF46BG, including repackagers and relabelers. The FDA regulates Ghv7HF46BG manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ghv7HF46BG API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ghv7HF46BG supplier is an individual or a company that provides Ghv7HF46BG active pharmaceutical ingredient (API) or Ghv7HF46BG finished formulations upon request. The Ghv7HF46BG suppliers may include Ghv7HF46BG API manufacturers, exporters, distributors and traders.
Ghv7HF46BG Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ghv7HF46BG GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ghv7HF46BG GMP manufacturer or Ghv7HF46BG GMP API supplier for your needs.
A Ghv7HF46BG CoA (Certificate of Analysis) is a formal document that attests to Ghv7HF46BG's compliance with Ghv7HF46BG specifications and serves as a tool for batch-level quality control.
Ghv7HF46BG CoA mostly includes findings from lab analyses of a specific batch. For each Ghv7HF46BG CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ghv7HF46BG may be tested according to a variety of international standards, such as European Pharmacopoeia (Ghv7HF46BG EP), Ghv7HF46BG JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ghv7HF46BG USP).
